March 2024
1. DENG T, Zhao J, Tong Y, Chen Z, et al
   Crosstalk between endothelial progenitor cells and HCC through periostin/CCL2/CD36 supports formation of the pro-metastatic microenvironment in HCC.
   Oncogene. 2024;43:944-961.
   

   >> Share

   
   February 2024
2. ZHANG T, Zhao F, Zhang Y, Shi JH, et al
   Targeting the IRE1alpha-XBP1s axis confers selective vulnerability in hepatocellular carcinoma with activated Wnt signaling.
   Oncogene. 2024 Feb 28. doi: 10.1038/s41388-024-02988.
   

   >> Share

   
   
3. FENG Z, Yin J, Zhang Z, Chen Z, et al
   O-GlcNAcylation of E3 ubiquitin ligase SKP2 promotes hepatocellular carcinoma proliferation.
   Oncogene. 2024 Feb 23. doi: 10.1038/s41388-024-02977.
   

   >> Share

   
   
4. LI B, Xiong X, Xu J, Peng D, et al
   METTL3-mediated m(6)A modification of lncRNA TSPAN12 promotes metastasis of hepatocellular carcinoma through SENP1-depentent deSUMOylation of EIF3I.
   Oncogene. 2024 Feb 19. doi: 10.1038/s41388-024-02970.
   

   >> Share

   
   January 2024
5. GENG L, Zhu M, Luo D, Chen H, et al
   TKT-PARP1 axis induces radioresistance by promoting DNA double-strand break repair in hepatocellular carcinoma.
   Oncogene. 2024 Jan 12. doi: 10.1038/s41388-023-02935.
   

   >> Share

   
   
6. GU X, Li P, Gao X, Ru Y, et al
   RNA 5-methylcytosine writer NSUN5 promotes hepatocellular carcinoma cell proliferation via a ZBED3-dependent mechanism.
   Oncogene. 2024 Jan 5. doi: 10.1038/s41388-023-02931.
   

   >> Share

   
   December 2023
7. WANG C, Chen Z, Yi Y, Ding Y, et al
   RBM45 reprograms lipid metabolism promoting hepatocellular carcinoma via Rictor and ACSL1/ACSL4.
   Oncogene. 2023 Dec 1. doi: 10.1038/s41388-023-02902.
   

   >> Share

   
   November 2023
8. CAO K, Wang R, Li L, Liao Y, et al
   Targeting DDX11 promotes PARP inhibitor sensitivity in hepatocellular carcinoma by attenuating BRCA2-RAD51 mediated homologous recombination.
   Oncogene. 2023 Nov 25. doi: 10.1038/s41388-023-02898.
   

   >> Share

   
   
9. CHEN J, Ning D, Du P, Liu Q, et al
   USP11 potentiates HGF/AKT signaling and drives metastasis in hepatocellular carcinoma.
   Oncogene. 2023 Nov 16. doi: 10.1038/s41388-023-02847.
   

   >> Share

   
   
10. LIU F, Liao Z, Zhang Z
    MYC in liver cancer: mechanisms and targeted therapy opportunities.
    Oncogene. 2023;42:3303-3318.
    

    >> Share

    
    September 2023
11. ZHOU J, Xu W, Wu Y, Wang M, et al
    GPR37 promotes colorectal cancer liver metastases by enhancing the glycolysis and histone lactylation via Hippo pathway.
    Oncogene. 2023 Sep 25. doi: 10.1038/s41388-023-02841.
    

    >> Share

    
    
12. YU A, Yu P, Zhu Y, Zhu R, et al
    Glucose-induced and ChREBP: MLX-mediated lipogenic program promotes hepatocellular carcinoma development.
    Oncogene. 2023 Sep 9. doi: 10.1038/s41388-023-02831.
    

    >> Share

    
    
13. DU D, Qin M, Shi L, Liu C, et al
    RNA binding motif protein 45-mediated phosphorylation enhances protein stability of ASCT2 to promote hepatocellular carcinoma progression.
    Oncogene. 2023 Sep 1. doi: 10.1038/s41388-023-02795.
    

    >> Share

    
    
14. QIAO X, Lin J, Shen J, Chen Y, et al
    FBXO28 suppresses liver cancer invasion and metastasis by promoting PKA-dependent SNAI2 degradation.
    Oncogene. 2023;42:2878-2891.
    

    >> Share

    
    August 2023
15. ZHANG X, Wu N, Huang H, Li S, et al
    Phosphorylated PTTG1 switches its subcellular distribution and promotes beta-catenin stabilization and subsequent transcription activity.
    Oncogene. 2023;42:2439-2455.
    

    >> Share

    
    July 2023
16. ZHANG H, Deng T, Ge S, Liu Y, et al
    Retraction Note: Exosome circRNA secreted from adipocytes promotes the growth of hepatocellular carcinoma by targeting deubiquitination-related USP7.
    Oncogene. 2023 Jul 24. doi: 10.1038/s41388-023-02786.
    

    >> Share

    
    
17. GAO J, Fang Y, Chen J, Tang Z, et al
    Methyltransferase like 3 inhibition limits intrahepatic cholangiocarcinoma metabolic reprogramming and potentiates the efficacy of chemotherapy.
    Oncogene. 2023 Jul 7. doi: 10.1038/s41388-023-02760.
    

    >> Share

    
    June 2023
18. HUANG P, Xu Q, Yan Y, Lu Y, et al
    Retraction Note: HBx/ERalpha complex-mediated LINC01352 downregulation promotes HBV-related hepatocellular carcinoma via the miR-135b-APC axis.
    Oncogene. 2023 Jun 26. doi: 10.1038/s41388-023-02753.
    

    >> Share

    
    
19. HU J, Liu N, Song D, Steer CJ, et al
    A positive feedback between cholesterol synthesis and the pentose phosphate pathway rather than glycolysis promotes hepatocellular carcinoma.
    Oncogene. 2023 Jun 26. doi: 10.1038/s41388-023-02757.
    

    >> Share

    
    
20. WANG L, Li G, Zhou Z, Ge C, et al
    Chromatin-associated OGT promotes the malignant progression of hepatocellular carcinoma by activating ZNF263.
    Oncogene. 2023 Jun 23. doi: 10.1038/s41388-023-02751.
    

    >> Share

    
    
21. MENG J, Chen S, Lei YY, Han JX, et al
    Retraction Note: Hsp90beta promotes aggressive vasculogenic mimicry via epithelial-mesenchymal transition in hepatocellular carcinoma.
    Oncogene. 2023 Jun 21. doi: 10.1038/s41388-023-02754.
    

    >> Share

    
    May 2023
22. WANG Y, Chen H
    Protein glycosylation alterations in hepatocellular carcinoma: function and clinical implications.
    Oncogene. 2023 May 16. doi: 10.1038/s41388-023-02702.
    

    >> Share

    
    
23. FENG Z, Ke S, Wang C, Lu S, et al
    RNF125 attenuates hepatocellular carcinoma progression by downregulating SRSF1-ERK pathway.
    Oncogene. 2023 May 4. doi: 10.1038/s41388-023-02710.
    

    >> Share

    
    April 2023
24. LI W, Han Q, Zhu Y, Zhou Y, et al
    SUMOylation of RNF146 results in Axin degradation and activation of Wnt/beta-catenin signaling to promote the progression of hepatocellular carcinoma.
    Oncogene. 2023 Apr 7. doi: 10.1038/s41388-023-02689.
    

    >> Share

    
    March 2023
25. ZHANG Q, Xiong L, Wei T, Liu Q, et al
    Hypoxia-responsive PPARGC1A/BAMBI/ACSL5 axis promotes progression and resistance to lenvatinib in hepatocellular carcinoma.
    Oncogene. 2023 Mar 17. doi: 10.1038/s41388-023-02665.
    

    >> Share

    
    
26. YANG X, Qu S, Wang L, Zhang H, et al
    Retraction Note: PTBP3 splicing factor promotes hepatocellular carcinoma by destroying the splicing balance of NEAT1 and pre-miR-612.
    Oncogene. 2023 Mar 8. doi: 10.1038/s41388-023-02648.
    

    >> Share

    
    
27. AKCE M, El-Rayes BF, Wajapeyee N
    Combinatorial targeting of immune checkpoints and epigenetic regulators for hepatocellular carcinoma therapy.
    Oncogene. 2023 Mar 1. doi: 10.1038/s41388-023-02646.
    

    >> Share

    
    February 2023
28. HAN L, Zhang C, Wang D, Zhang J, et al
    Retrograde regulation of mitochondrial fission and epithelial to mesenchymal transition in hepatocellular carcinoma by GCN5L1.
    Oncogene. 2023 Feb 9. doi: 10.1038/s41388-023-02621.
    

    >> Share

    
    January 2023
29. ZHOU P, Chang WY, Gong DA, Huang LY, et al
    O-GlcNAcylation of SPOP promotes carcinogenesis in hepatocellular carcinoma.
    Oncogene. 2023 Jan 5. doi: 10.1038/s41388-022-02589.
    

    >> Share

    
    December 2022
30. ZOU X, Lu J, Deng Y, Liu Q, et al
    ST6GAL1 inhibits metastasis of hepatocellular carcinoma via modulating sialylation of MCAM on cell surface.
    Oncogene. 2022 Dec 17. doi: 10.1038/s41388-022-02571.
    

    >> Share

    
    
31. LIU Y, Sun L, Guo H, Zhou S, et al
    Targeting SLP2-mediated lipid metabolism reprograming restricts proliferation and metastasis of hepatocellular carcinoma and promotes sensitivity to Lenvatinib.
    Oncogene. 2022 Dec 6. doi: 10.1038/s41388-022-02551.
    

    >> Share

    
    November 2022
32. ZHENG M, Ai Z, Guo Y, Chen Y, et al
    Imbalance in ALR ubiquitination accelerates the progression of nonalcoholic steatohepatitis to hepatocellular carcinoma.
    Oncogene. 2022 Nov 25. doi: 10.1038/s41388-022-02549.
    

    >> Share

    
    
33. JIN C, Han-Hua D, Qiu-Meng L, Deng N, et al
    MTDH-stabilized DDX17 promotes tumor initiation and progression through interacting with YB1 to induce EGFR transcription in Hepatocellular Carcinoma.
    Oncogene. 2022 Nov 17. pii: 10.1038/s41388-022-02545.
    

    >> Share

    
    
34. ZHANG H, Liao Z, Wang W, Liu Y, et al
    A micropeptide JunBP regulated by TGF-beta promotes hepatocellular carcinoma metastasis.
    Oncogene. 2022 Nov 15. pii: 10.1038/s41388-022-02518.
    

    >> Share

    
    
35. XU C, Gu L, Kuerbanjiang M, Jiang C, et al
    Adaptive activation of EFNB2/EPHB4 axis promotes post-metastatic growth of colorectal cancer liver metastases by LDLR-mediated cholesterol uptake.
    Oncogene. 2022 Nov 14. pii: 10.1038/s41388-022-02519.
    

    >> Share

    
    
36. MA M, Zhang C, Cao R, Tang D, et al
    UBE2O promotes lipid metabolic reprogramming and liver cancer progression by mediating HADHA ubiquitination.
    Oncogene. 2022;41:5199-5213.
    

    >> Share

    
    October 2022
37. WANG X, Liu Y, Han A, Tang C, et al
    The NQO1/p53/SREBP1 axis promotes hepatocellular carcinoma progression and metastasis by regulating Snail stability.
    Oncogene. 2022 Oct 17. pii: 10.1038/s41388-022-02477.
    

    >> Share

    
    September 2022
38. LI T, Xie J, Shen C, Cheng D, et al
    Retraction Note: Upregulation of long noncoding RNA ZEB1-AS1 promotes tumor metastasis and predicts poor prognosis in hepatocellular carcinoma.
    Oncogene. 2022 Sep 30. pii: 10.1038/s41388-022-02480.
    

    >> Share

    
    
39. CHAND V, Liao X, Guzman G, Benevolenskaya E, et al
    Correction: Hepatocellular carcinoma evades RB1-induced senescence by activating the FOXM1-FOXO1 axis.
    Oncogene. 2022 Sep 7. pii: 10.1038/s41388-022-02436.
    

    >> Share

    
    
40. DISKIN B, Adam S, Soto GS, Liria M, et al
    BTLA(+)CD200(+) B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancer.
    Oncogene. 2022;41:4349-4360.
    

    >> Share

    
    August 2022
41. GAO M, Qi Z, Deng M, Huang H, et al
    The deubiquitinase USP7 regulates oxidative stress through stabilization of HO-1.
    Oncogene. 2022;41:4018-4027.
    

    >> Share

    
    July 2022
42. DOU C, Zhou Z, Xu Q, Liu Z, et al
    Correction: Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca(2+)/PI3K/AKT pathway.
    Oncogene. 2022 Jul 27. pii: 10.1038/s41388-022-02421.
    

    >> Share

    
    
43. DONG P, Cai Z, Li B, Zhu Y, et al
    HFE promotes mitotic cell division through recruitment of cytokinetic abscission machinery in hepatocellular carcinoma.
    Oncogene. 2022 Jul 26. pii: 10.1038/s41388-022-02419.
    

    >> Share

    
    
44. YING C, Jin C, Zeng S, Chao M, et al
    Alkalization of cellular pH leads to cancer cell death by disrupting autophagy and mitochondrial function.
    Oncogene. 2022;41:3886-3897.
    

    >> Share

    
    June 2022
45. PAN D, Yang W, Zeng Y, Qin H, et al
    AKR1C3 regulated by NRF2/MAFG complex promotes proliferation via stabilizing PARP1 in hepatocellular carcinoma.
    Oncogene. 2022 Jun 30. pii: 10.1038/s41388-022-02379.
    

    >> Share

    
    
46. CHAND V, Liao X, Guzman G, Benevolenskaya E, et al
    Hepatocellular carcinoma evades RB1-induced senescence by activating the FOXM1-FOXO1 axis.
    Oncogene. 2022 Jun 27. pii: 10.1038/s41388-022-02394.
    

    >> Share

    
    
47. WANG Y, Zhang Y, Mi J, Jiang C, et al
    ANKFN1 plays both protumorigenic and metastatic roles in hepatocellular carcinoma.
    Oncogene. 2022 Jun 21. pii: 10.1038/s41388-022-02380.
    

    >> Share

    
    
48. MA XL, Zhu KY, Chen YD, Tang WG, et al
    Identification of a novel Calpain-2-SRC feed-back loop as necessity for beta-Catenin accumulation and signaling activation in hepatocellular carcinoma.
    Oncogene. 2022 Jun 13. pii: 10.1038/s41388-022-02367.
    

    >> Share

    
    
49. LIU Y, Ouyang L, Mao C, Chen Y, et al
    PCDHB14 promotes ferroptosis and is a novel tumor suppressor in hepatocellular carcinoma.
    Oncogene. 2022 Jun 10. pii: 10.1038/s41388-022-02370.
    

    >> Share

    
    May 2022
50. CHEN S, Cheng J, Zhong Y, Liu R, et al
    Correction: Liver-specific overexpression of Gab2 accelerates hepatocellular carcinoma progression by activating immunosuppression of myeloid-derived suppressor cells.
    Oncogene. 2022 May 6. pii: 10.1038/s41388-022-02337.
    

    >> Share

    
    April 2022
51. LI K, Niu Y, Yuan Y, Qiu J, et al
    Insufficient ablation induces E3-ligase Nedd4 to promote hepatocellular carcinoma progression by tuning TGF-beta signaling.
    Oncogene. 2022 Apr 30. pii: 10.1038/s41388-022-02334.
    

    >> Share

    
    
52. CHEN J, Li Z, Jia X, Song W, et al
    Targeting anillin inhibits tumorigenesis and tumor growth in hepatocellular carcinoma via impairing cytokinesis fidelity.
    Oncogene. 2022 Apr 27. pii: 10.1038/s41388-022-02274.
    

    >> Share

    
    
53. TSAI YT, Li CY, Huang YH, Chang TS, et al
    Galectin-1 orchestrates an inflammatory tumor-stroma crosstalk in hepatoma by enhancing TNFR1 protein stability and signaling in carcinoma-associated fibroblasts.
    Oncogene. 2022 Apr 22. pii: 10.1038/s41388-022-02309.
    

    >> Share

    
    
54. HOCHNADEL I, Hoenicke L, Petriv N, Neubert L, et al
    Correction: Safety and efficacy of prophylactic and therapeutic vaccine based on live-attenuated Listeria monocytogenes in hepatobiliary cancers.
    Oncogene. 2022 Apr 13. pii: 10.1038/s41388-022-02261.
    

    >> Share

    
    
55. CHEN S, Cheng J, Zhong Y, Liu R, et al
    Liver-specific overexpression of Gab2 accelerates hepatocellular carcinoma progression by activating immunosuppression of myeloid-derived suppressor cells.
    Oncogene. 2022 Apr 11. pii: 10.1038/s41388-022-02298.
    

    >> Share

    
    March 2022
56. CHEN X, Wang Z, Zhao X, Zhang L, et al
    STAT5A modulates CDYL2/SLC7A6 pathway to inhibit the proliferation and invasion of hepatocellular carcinoma by targeting to mTORC1.
    Oncogene. 2022 Mar 21. pii: 10.1038/s41388-022-02273.
    

    >> Share

    
    
57. GU Y, Guo Y, Gao N, Fang Y, et al
    The proteomic characterization of the peritumor microenvironment in human hepatocellular carcinoma.
    Oncogene. 2022 Mar 21. pii: 10.1038/s41388-022-02264.
    

    >> Share

    
    
58. WU WR, Shi XD, Zhang FP, Zhu K, et al
    Activation of the Notch1-c-myc-VCAM1 signalling axis initiates liver progenitor cell-driven hepatocarcinogenesis and pulmonary metastasis.
    Oncogene. 2022 Mar 7. pii: 10.1038/s41388-022-02246.
    

    >> Share

    
    
59. LV B, Pan Y, Hou D, Chen P, et al
    RNF4 silencing induces cell growth arrest and DNA damage by promoting nuclear targeting of p62 in hepatocellular carcinoma.
    Oncogene. 2022 Mar 2. pii: 10.1038/s41388-022-02247.
    

    >> Share

    
    
60. HAN L, Lin X, Yan Q, Gu C, et al
    PBLD inhibits angiogenesis via impeding VEGF/VEGFR2-mediated microenvironmental cross-talk between HCC cells and endothelial cells.
    Oncogene. 2022;41:1851-1865.
    

    >> Share

    
    
61. RAO VS, Gu Q, Tzschentke S, Lin K, et al
    Extravesicular TIMP-1 is a non-invasive independent prognostic marker and potential therapeutic target in colorectal liver metastases.
    Oncogene. 2022;41:1809-1820.
    

    >> Share

    
    
62. JOURNO S, Goldberg AK, Sokol ES, Zinger L, et al
    Genomic alterations drive metastases formation in pancreatic ductal adenocarcinoma cancer: deciphering the role of CDKN2A and CDKN2B in mediating liver tropism.
    Oncogene. 2022;41:1468-1481.
    

    >> Share

    
    February 2022
63. JI X, Chen X, Zhang B, Xie M, et al
    T-box transcription factor 19 promotes hepatocellular carcinoma metastasis through upregulating EGFR and RAC1.
    Oncogene. 2022 Feb 26. pii: 10.1038/s41388-022-02249.
    

    >> Share

    
    
64. HOCHNADEL I, Hoenicke L, Petriv N, Neubert L, et al
    Safety and efficacy of prophylactic and therapeutic vaccine based on live-attenuated Listeria monocytogenes in hepatobiliary cancers.
    Oncogene. 2022 Feb 16. pii: 10.1038/s41388-022-02222.
    

    >> Share

    
    
65. LI B, Kang H, Xiao Y, Du Y, et al
    LncRNA GAL promotes colorectal cancer liver metastasis through stabilizing GLUT1.
    Oncogene. 2022 Feb 11. pii: 10.1038/s41388-022-02230.
    

    >> Share

    
    
66. ZHANG X, Hu Y, Pan Y, Xiong Y, et al
    DDR1 promotes hepatocellular carcinoma metastasis through recruiting PSD4 to ARF6.
    Oncogene. 2022 Feb 9. pii: 10.1038/s41388-022-02212.
    

    >> Share

    
    
67. DESI N, Teh V, Tong QY, Lim CY, et al
    MiR-138 is a potent regulator of the heterogenous MYC transcript population in cancers.
    Oncogene. 2022;41:1178-1189.
    

    >> Share

    
    January 2022
68. XU QC, Tien YC, Shi YH, Chen S, et al
    METTL3 promotes intrahepatic cholangiocarcinoma progression by regulating IFIT2 expression in an m(6)A-YTHDF2-dependent manner.
    Oncogene. 2022 Jan 29. pii: 10.1038/s41388-022-02185.
    

    >> Share

    
    
69. CHIAVARINA B, Ronca R, Otaka Y, Sutton RB, et al
    Fibroblast-derived prolargin is a tumor suppressor in hepatocellular carcinoma.
    Oncogene. 2022 Jan 14. pii: 10.1038/s41388-021-02171.
    

    >> Share

    
    
70. HE DD, Shang XY, Wang N, Wang GX, et al
    BRD4 inhibition induces synthetic lethality in ARID2-deficient hepatocellular carcinoma by increasing DNA damage.
    Oncogene. 2022 Jan 11. pii: 10.1038/s41388-022-02176.
    

    >> Share

    
    December 2021
71. LIU R, Gou D, Xiang J, Pan X, et al
    O-GlcNAc modified-TIP60/KAT5 is required for PCK1 deficiency-induced HCC metastasis.
    Oncogene. 2021;40:6707-6719.
    

    >> Share

    
    November 2021
72. SUN L, Xi S, Zhou Z, Zhang F, et al
    Elevated expression of RIT1 hyperactivates RAS/MAPK signal and sensitizes hepatocellular carcinoma to combined treatment with sorafenib and AKT inhibitor.
    Oncogene. 2021 Nov 29. pii: 10.1038/s41388-021-02130.
    

    >> Share

    
    
73. GILL T, Wang H, Bandaru R, Lawlor M, et al
    Selective targeting of MYC mRNA by stabilized antisense oligonucleotides.
    Oncogene. 2021;40:6527-6539.
    

    >> Share

    
    September 2021
74. LI B, Xia Y, Lv J, Wang W, et al
    miR-151a-3p-rich small extracellular vesicles derived from gastric cancer accelerate liver metastasis via initiating a hepatic stemness-enhancing niche.
    Oncogene. 2021 Sep 17. pii: 10.1038/s41388-021-02011.
    

    >> Share

    
    
75. LU L, Zhang J, Fan W, Li Y, et al
    Deregulated 14-3-3zeta and methionine adenosyltransferase alpha1 interplay promotes liver cancer tumorigenesis in mice and humans.
    Oncogene. 2021;40:5866-5879.
    

    >> Share

    
    
76. ZHANG X, Dou P, Akhtar ML, Liu F, et al
    NEU4 inhibits motility of HCC cells by cleaving sialic acids on CD44.
    Oncogene. 2021;40:5427-5440.
    

    >> Share

    
    August 2021
77. QIU P, Hou W, Wang H, Lei KKW, et al
    Sirt1 deficiency upregulates glutathione metabolism to prevent hepatocellular carcinoma initiation in mice.
    Oncogene. 2021 Aug 25. pii: 10.1038/s41388-021-01993.
    

    >> Share

    
    
78. SHERMAN J, Verstandig G, Brumer Y
    Application of machine learning to large in-vitro databases to identify cancer cell characteristics: telomerase reverse transcriptase (TERT) expression.
    Oncogene. 2021;40:5038-5041.
    

    >> Share

    
    July 2021
79. LIU Z, Wang A, Pu Y, Li Z, et al
    Genomic and transcriptomic profiling of hepatoid adenocarcinoma of the stomach.
    Oncogene. 2021 Jul 30. pii: 10.1038/s41388-021-01976.
    

    >> Share

    
    
80. ZHANG Y, Yan Q, Gong L, Xu H, et al
    Correction: C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism.
    Oncogene. 2021 Jul 26. pii: 10.1038/s41388-021-01942.
    

    >> Share

    
    
81. BRAHMA MK, Gilglioni EH, Zhou L, Trepo E, et al
    Oxidative stress in obesity-associated hepatocellular carcinoma: sources, signaling and therapeutic challenges.
    Oncogene. 2021 Jul 21. pii: 10.1038/s41388-021-01950.
    

    >> Share

    
    
82. ZHANG EB, Zhang X, Wang K, Zhang F, et al
    Antifungal agent Terbinafine restrains tumor growth in preclinical models of hepatocellular carcinoma via AMPK-mTOR axis.
    Oncogene. 2021 Jul 10. pii: 10.1038/s41388-021-01934.
    

    >> Share

    
    
83. XU F, Jiang L, Zhao Q, Zhang Z, et al
    Whole-transcriptome and proteome analyses identify key differentially expressed mRNAs, miRNAs, lncRNAs and circRNAs associated with HCC.
    Oncogene. 2021;40:4820-4831.
    

    >> Share

    
    June 2021
84. ZHAO S, Guan B, Mi Y, Shi D, et al
    LncRNA MIR17HG promotes colorectal cancer liver metastasis by mediating a glycolysis-associated positive feedback circuit.
    Oncogene. 2021 Jun 18. pii: 10.1038/s41388-021-01859.
    

    >> Share

    
    
85. LIN YH, Wu MH, Liu YC, Lyu PC, et al
    LINC01348 suppresses hepatocellular carcinoma metastasis through inhibition of SF3B3-mediated EZH2 pre-mRNA splicing.
    Oncogene. 2021 Jun 17. pii: 10.1038/s41388-021-01905.
    

    >> Share

    
    
86. WANG S, Cao K, Liao Y, Zhang W, et al
    CDCA2 protects against oxidative stress by promoting BRCA1-NRF2 signaling in hepatocellular carcinoma.
    Oncogene. 2021 Jun 8. pii: 10.1038/s41388-021-01855.
    

    >> Share

    
    
87. WANG X, Dong J, Li X, Cheng Z, et al
    CPSF4 regulates circRNA formation and microRNA mediated gene silencing in hepatocellular carcinoma.
    Oncogene. 2021 Jun 8. pii: 10.1038/s41388-021-01867.
    

    >> Share

    
    
88. SHEN M, Zhang R, Jia W, Zhu Z, et al
    Nuclear scaffold protein p54(nrb)/NONO facilitates the hypoxia-enhanced progression of hepatocellular carcinoma.
    Oncogene. 2021 Jun 2. pii: 10.1038/s41388-021-01848.
    

    >> Share

    
    
89. WANG Y, Yu H, Xie X, Deng T, et al
    Plasmalemma vesicle-associated protein promotes angiogenesis in cholangiocarcinoma via the DKK1/CKAP4/PI3K signaling pathway.
    Oncogene. 2021;40:4324-4337.
    

    >> Share

    
    May 2021
90. CAROTTI S, Zingariello M, Francesconi M, D'Andrea L, et al
    Fragile X mental retardation protein in intrahepatic cholangiocarcinoma: regulating the cancer cell behavior plasticity at the leading edge.
    Oncogene. 2021 May 20. pii: 10.1038/s41388-021-01824.
    

    >> Share

    
    
91. ZHANG XL, Hu LP, Yang Q, Qin WT, et al
    CTHRC1 promotes liver metastasis by reshaping infiltrated macrophages through physical interactions with TGF-beta receptors in colorectal cancer.
    Oncogene. 2021 May 13. pii: 10.1038/s41388-021-01827.
    

    >> Share

    
    April 2021
92. CHEN S, Du Y, Xu B, Li Q, et al
    Vaccinia-related kinase 2 blunts sorafenib's efficacy against hepatocellular carcinoma by disturbing the apoptosis-autophagy balance.
    Oncogene. 2021 Apr 19. pii: 10.1038/s41388-021-01780.
    

    >> Share

    
    
93. CHEN K, Hou Y, Liao R, Li Y, et al
    LncRNA SNHG6 promotes G1/S-phase transition in hepatocellular carcinoma by impairing miR-204-5p-mediated inhibition of E2F1.
    Oncogene. 2021 Apr 6. pii: 10.1038/s41388-021-01671.
    

    >> Share

    
    
94. LAO M, Zhang X, Ma T, Xu J, et al
    Regulator of calcineurin 1 gene isoform 4 in pancreatic ductal adenocarcinoma regulates the progression of tumor cells.
    Oncogene. 2021;40:3136-3151.
    

    >> Share

    
    
95. PAN Z, Liu C, Zhi Y, Xie Z, et al
    LIMK1 nuclear translocation promotes hepatocellular carcinoma progression by increasing p-ERK nuclear shuttling and by activating c-Myc signalling upon EGF stimulation.
    Oncogene. 2021;40:2581-2595.
    

    >> Share

    
    February 2021
96. LUO JH, Liu S, Tao J, Ren BG, et al
    Pten-NOLC1 fusion promotes cancers involving MET and EGFR signalings.
    Oncogene. 2021;40:1064-1076.
    

    >> Share

    
    October 2020
97. NIMMAKAYALA RK, Leon F, Rachagani S, Rauth S, et al
    Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma.
    Oncogene. 2020 Oct 27. pii: 10.1038/s41388-020-01518.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share